Trial Profile
A dose-escalation phase I study of Glutazumab in healthy male volunteers: A first-in-human, double-blind study
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Jan 2018
Price :
$35
*
At a glance
- Drugs Glutazumab (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; First in man; Pharmacokinetics
- 12 Jan 2018 New trial record
- 08 Dec 2017 Results presented at the 2017 Congress of the International Diabetes Federation